Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique L Brooks

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cell Stem Cell|December 3, 2021
Detoxifying chemotherapy with genetics-guided stem cell modeling: A personalized affairDominique L Brooks, Kiran Musunuru
HGG Advances|May 26, 2024
Response to Harding and MartinezDominique L Brooks, Kiran Musunuru, Xiao Wang
American Journal of Human Genetics|November 4, 2023
Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical needDominique L Brooks, Madelynn N Whittaker, Ping Qu, et al.
Communications Biology|January 30, 2021
Hallmarks of primary neurulation are conserved in the zebrafish forebrainJonathan M Werner, Maraki Y Negesse, Dominique L Brooks, et al.
Nature Communications|June 10, 2023
Rapid and definitive treatment of phenylketonuria in variant-humanized mice with corrective editingDominique L Brooks, Manuel J Carrasco, Ping Qu, et al.
HGG Advances|November 3, 2023
A base editing strategy using mRNA-LNPs for in vivo correction of the most frequent phenylketonuria variantDominique L Brooks, Madelynn N Whittaker, Hooda Said, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Improved specificity and efficacy of base-editing therapies with hybrid guide RNAsMadelynn N Whittaker, Dominique L Brooks, Aidan Quigley, et al.
American Journal of Human Genetics|April 2, 2026
Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platformEmily R Feierman, Madelynn N Whittaker, Aidan Quigley, et al.
Nature Biomedical Engineering|October 29, 2025
Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAsMadelynn N Whittaker, Lauren C Testa, Aidan Quigley, et al.
Nature Nanotechnology|June 15, 2026
Efficient prime editing in vivo and in vitro using lipid nanoparticlesAllen Y Jiang, Ana Cristian, Dominique L Brooks, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cell Stem Cell|December 3, 2021
Detoxifying chemotherapy with genetics-guided stem cell modeling: A personalized affairDominique L Brooks, Kiran Musunuru
HGG Advances|May 26, 2024
Response to Harding and MartinezDominique L Brooks, Kiran Musunuru, Xiao Wang
American Journal of Human Genetics|November 4, 2023
Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical needDominique L Brooks, Madelynn N Whittaker, Ping Qu, et al.
Communications Biology|January 30, 2021
Hallmarks of primary neurulation are conserved in the zebrafish forebrainJonathan M Werner, Maraki Y Negesse, Dominique L Brooks, et al.
Nature Communications|June 10, 2023
Rapid and definitive treatment of phenylketonuria in variant-humanized mice with corrective editingDominique L Brooks, Manuel J Carrasco, Ping Qu, et al.
HGG Advances|November 3, 2023
A base editing strategy using mRNA-LNPs for in vivo correction of the most frequent phenylketonuria variantDominique L Brooks, Madelynn N Whittaker, Hooda Said, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Improved specificity and efficacy of base-editing therapies with hybrid guide RNAsMadelynn N Whittaker, Dominique L Brooks, Aidan Quigley, et al.
American Journal of Human Genetics|April 2, 2026
Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platformEmily R Feierman, Madelynn N Whittaker, Aidan Quigley, et al.
Nature Biomedical Engineering|October 29, 2025
Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAsMadelynn N Whittaker, Lauren C Testa, Aidan Quigley, et al.
Nature Nanotechnology|June 15, 2026
Efficient prime editing in vivo and in vitro using lipid nanoparticlesAllen Y Jiang, Ana Cristian, Dominique L Brooks, et al.
Pageof 1